Galvani Bioelectronics, a clinical-stage therapeutics company formed through a strategic partnership between GSK and Verily Life Sciences to develop targeted neuromodulation therapies, announced it...
Industry leader with substantial U.S. and global experience in drug development and medical affairs joins Lyra as the Company's late-stage product candidates advance in the...
Lyra Therapeutics, Inc., a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained and local delivery of medications to the ear,...